• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53 protein overexpression and gene mutation in mixed Müllerian tumors of the uterus.

作者信息

Soong R, Knowles S, Hammond I G, Michael C, Iacopetta B J

机构信息

Department of Surgery, University of Western Australia, Nedlands, Australia.

出版信息

Cancer Detect Prev. 1999;23(1):8-12. doi: 10.1046/j.1525-1500.1999.00062.x.

DOI:10.1046/j.1525-1500.1999.00062.x
PMID:9892985
Abstract

Alteration of the p53 tumor suppressor gene is associated with poor prognosis in many human cancer types. We examined the incidence and prognostic significance of p53 gene alterations in a series of uterine malignant mixed Müllerian tumors (MMT). Nuclear overexpression of p53 protein detected by immunohistochemistry (IHC) with the DO-7 antibody was observed in 12 of 24 (50%) tumors. Mutation of the p53 gene detected by single-strand conformation polymorphism (SSCP) of exons 5 to 8 was found in 11 of 24 (46%) tumors. The incidence of p53 alteration in uterine MMT was significantly higher than in several common epithelial tumor cell types previously investigated in our laboratory using identical techniques. However, unlike these tumors alteration of the p53 gene does not appear to be of prognostic importance in uterine MMT.

摘要

相似文献

1
p53 protein overexpression and gene mutation in mixed Müllerian tumors of the uterus.
Cancer Detect Prev. 1999;23(1):8-12. doi: 10.1046/j.1525-1500.1999.00062.x.
2
Carcinosarcomas (malignant mixed mullerian tumors) of the female genital tract: comparative molecular analysis of epithelial and mesenchymal components.女性生殖道癌肉瘤(恶性混合性苗勒管肿瘤):上皮和间充质成分的比较分子分析
Hum Pathol. 1998 Jan;29(1):82-7. doi: 10.1016/s0046-8177(98)90394-x.
3
Role of p53 pathway alterations in uterine carcinosarcomas (malignant mixed Müllerian tumors).p53信号通路改变在子宫癌肉瘤(恶性混合性苗勒管肿瘤)中的作用。
Oncology. 2014;87(4):193-204. doi: 10.1159/000363574. Epub 2014 Jul 11.
4
Uterine sarcomas express KIT protein but lack mutation(s) in exon 11 or 17 of c-KIT.子宫肉瘤表达KIT蛋白,但c-KIT基因第11或17外显子不存在突变。
Gynecol Oncol. 2003 Oct;91(1):9-14. doi: 10.1016/s0090-8258(03)00442-6.
5
p53 immunoreactivity and mutation of the p53 gene in smooth muscle tumours of the uterine corpus.子宫体平滑肌肿瘤中p53免疫反应性及p53基因突变
J Pathol. 1995 Sep;177(1):65-70. doi: 10.1002/path.1711770111.
6
Malignant mixed Müllerian tumors of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 44 cases.子宫恶性混合性苗勒管肿瘤:44例病例的临床病理、DNA流式细胞术、p53及mdm-2分析
Gynecol Oncol. 1998 Jan;68(1):18-24. doi: 10.1006/gyno.1997.4892.
7
Nuclear overexpression of p53 protein does not correlate with gene mutation in primary peritoneal carcinoma.原发性腹膜癌中p53蛋白的核过表达与基因突变不相关。
Hum Pathol. 1997 Sep;28(9):1002-6. doi: 10.1016/s0046-8177(97)90051-4.
8
Frequent occurrence of p53 gene mutations in uterine cancers at advanced clinical stage and with aggressive histological phenotypes.p53基因突变在临床晚期及具有侵袭性组织学表型的子宫癌中频繁发生。
Jpn J Cancer Res. 1992 Nov;83(11):1184-91. doi: 10.1111/j.1349-7006.1992.tb02743.x.
9
Carcinosarcomas (malignant mullerian mixed tumors) of the uterus and ovary: a genetic study with special reference to histogenesis.子宫和卵巢的癌肉瘤(恶性苗勒管混合瘤):一项特别涉及组织发生的遗传学研究
Int J Gynecol Pathol. 2003 Oct;22(4):368-73. doi: 10.1097/01.pgp.0000092134.88121.56.
10
Molecular genetic evidence for the conversion hypothesis of the origin of malignant mixed müllerian tumours.恶性混合性苗勒管肿瘤起源的转化假说的分子遗传学证据。
J Pathol. 1997 Dec;183(4):424-31. doi: 10.1002/(SICI)1096-9896(199712)183:4<424::AID-PATH949>3.0.CO;2-L.

引用本文的文献

1
[p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumor aggressiveness in humans].[p53抑制小鼠II型子宫内膜癌并调控人类子宫内膜肿瘤侵袭性]
Pathologe. 2013 Nov;34 Suppl 2:180-8. doi: 10.1007/s00292-013-1859-x.
2
p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans.p53 抑制小鼠的 II 型子宫内膜癌,并控制人类子宫内膜肿瘤的侵袭性。
EMBO Mol Med. 2012 Aug;4(8):808-24. doi: 10.1002/emmm.201101063. Epub 2012 Jun 8.
3
Malignant mixed Mullerian tumors of the uterus: histopathological evaluation of cell cycle and apoptotic regulatory proteins.
子宫恶性混合性苗勒管肿瘤:细胞周期和凋亡调控蛋白的组织病理学评估。
World J Surg Oncol. 2010 Jul 19;8:60. doi: 10.1186/1477-7819-8-60.
4
Molecular genetic aberrations of ovarian and uterine carcinosarcomas--a CGH and FISH study.卵巢和子宫癌肉瘤的分子遗传学畸变——一项比较基因组杂交和荧光原位杂交研究
Virchows Arch. 2008 Mar;452(3):259-68. doi: 10.1007/s00428-007-0557-6.